- Home
- SLNO vs NTB Comparison
SLNO vs NTB Comparison
Compare SLNO & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- NTB
- Stock Information
- Founded
- SLNO 1999
- NTB 1858
- Country
- SLNO United States
- NTB Bermuda
- Employees
- SLNO N/A
- NTB N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NTB Commercial Banks
- Sector
- SLNO Health Care
- NTB Finance
- Exchange
- SLNO Nasdaq
- NTB Nasdaq
- Market Cap
- SLNO 1.9B
- NTB 1.5B
- IPO Year
- SLNO 2014
- NTB 2016
- Fundamental
- Price
- SLNO $48.54
- NTB $36.68
- Analyst Decision
- SLNO Strong Buy
- NTB Buy
- Analyst Count
- SLNO 7
- NTB 6
- Target Price
- SLNO $67.14
- NTB $37.83
- AVG Volume (30 Days)
- SLNO 567.3K
- NTB 160.9K
- Earning Date
- SLNO 08-07-2024
- NTB 10-22-2024
- Dividend Yield
- SLNO N/A
- NTB 4.80%
- EPS Growth
- SLNO N/A
- NTB N/A
- EPS
- SLNO N/A
- NTB 4.33
- Revenue
- SLNO N/A
- NTB $572,035,000.00
- Revenue This Year
- SLNO N/A
- NTB N/A
- Revenue Next Year
- SLNO N/A
- NTB N/A
- P/E Ratio
- SLNO N/A
- NTB $8.47
- Revenue Growth
- SLNO N/A
- NTB N/A
- 52 Week Low
- SLNO $3.73
- NTB $24.62
- 52 Week High
- SLNO $53.82
- NTB $40.55
- Technical
- Relative Strength Index (RSI)
- SLNO 53.45
- NTB 46.86
- Support Level
- SLNO $45.90
- NTB $37.55
- Resistance Level
- SLNO $49.61
- NTB $38.47
- Average True Range (ATR)
- SLNO 2.71
- NTB 0.83
- MACD
- SLNO -2.71
- NTB -0.01
- Stochastic Oscillator
- SLNO 92.67
- NTB 20.45
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
About NTB Bank of N.T. Butterfield & Son Limited (The) Voting
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, the Cayman Islands, the Channel Islands, and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.